379 related articles for article (PubMed ID: 12393611)
61. Cytokine receptor common beta subunit-mediated STAT5 activation confers NF-kappa B activation in murine proB cell line Ba/F3 cells.
Nakamura T; Ouchida R; Kodama T; Kawashima T; Makino Y; Yoshikawa N; Watanabe S; Morimoto C; Kitamura T; Tanaka H
J Biol Chem; 2002 Feb; 277(8):6254-65. PubMed ID: 11741913
[TBL] [Abstract][Full Text] [Related]
62. E2F inhibits transcriptional activation by the retinoic acid receptor.
Costa SL; Pratt MA; McBurney MW
Cell Growth Differ; 1996 Nov; 7(11):1479-85. PubMed ID: 8930397
[TBL] [Abstract][Full Text] [Related]
63. Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter.
Wood TJ; Sliva D; Lobie PE; Goullieux F; Mui AL; Groner B; Norstedt G; Haldosén LA
Mol Cell Endocrinol; 1997 Jun; 130(1-2):69-81. PubMed ID: 9220023
[TBL] [Abstract][Full Text] [Related]
64. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
65. Growth hormone signal transduction.
Piwien-Pilipuk G; Huo JS; Schwartz J
J Pediatr Endocrinol Metab; 2002 Jun; 15(6):771-86. PubMed ID: 12099386
[TBL] [Abstract][Full Text] [Related]
66. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
67. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
Hoover RR; Gerlach MJ; Koh EY; Daley GQ
Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
[TBL] [Abstract][Full Text] [Related]
68. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
69. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
Erickson-Miller CL; Pelus LM; Lord KA
Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
[TBL] [Abstract][Full Text] [Related]
70. Characterization of cis-acting sequences and trans-acting signals regulating early growth response 1 and c-fos promoters through the granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells.
Watanabe S; Kubota H; Sakamoto KM; Arai K
Blood; 1997 Feb; 89(4):1197-206. PubMed ID: 9028942
[TBL] [Abstract][Full Text] [Related]
71. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
Moon JJ; Nelson BH
J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
[TBL] [Abstract][Full Text] [Related]
72. Ras and signal transducer and activator of transcription (STAT) are essential and sufficient downstream components of Janus kinases in cell proliferation.
Mizuguchi R; Noto S; Yamada M; Ashizawa S; Higashi H; Hatakeyama M
Jpn J Cancer Res; 2000 May; 91(5):527-33. PubMed ID: 10835498
[TBL] [Abstract][Full Text] [Related]
73. JAK/STAT-dependent gene regulation by cytokines.
Hebenstreit D; Horejs-Hoeck J; Duschl A
Drug News Perspect; 2005 May; 18(4):243-9. PubMed ID: 16034480
[TBL] [Abstract][Full Text] [Related]
74. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
75. Role of STAT5 in interferon-alpha signal transduction in Ba/F3 cells.
Jaster R; Tschirch E; Bittorf T; Brock J
Cell Signal; 1999 May; 11(5):331-5. PubMed ID: 10376805
[TBL] [Abstract][Full Text] [Related]
76. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
Eur Cytokine Netw; 1999 Dec; 10(4):479-90. PubMed ID: 10586114
[TBL] [Abstract][Full Text] [Related]
77. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
78. A role for cofactors in synergistic and cell-specific activation by retinoic acid receptors and retinoid X receptor.
Folkers GE; Van der Burg B; Van der Saag PT
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):119-29. PubMed ID: 8603032
[TBL] [Abstract][Full Text] [Related]
79. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
80. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
